Company intelligence / Profile preview
Cyrano Therapeutics
Delray Beach, Florida, United Statescyranotherapeutics.com ↗
- Ownership
- Private
- Employees
- ~6
- Development stage
- Other
01
Overview
Currently conducting a 32-week, randomized, double-blinded, placebo-controlled Phase 2 trial evaluating the safety and effectiveness of CYR-064 for hyposmia. A previous 92-patient pilot study showed success. Data readout from the current trial is expected in Q1 2025.
- Therapeutic areas
- Neurology
- Modalities
- Intranasal formulation
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Cyrano Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cyrano Therapeutics.